Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.28
Delayed Data
As of Feb 09
 -0.0299 / -2.28%
Today’s Change
0.82
Today|||52-Week Range
2.87
-9.22%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.31
Today’s open1.21
Day’s range1.16 - 1.29
Volume3,300
Average volume (3 months)8,296
Market cap$15.6M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+1.68%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...-0.07-2.04%
EVOKEvoke Pharma Inc-0.07-2.47%
--Medicine Man Technol...-0.30-13.33%
ATOSAtossa Genetics Inc-0.01-4.17%
Data as of 3:55pm ET, 02/09/2016

Financials

Next reporting dateMarch 17, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts

Partner Offers